Skip to content
AdminOct 4, 2019< 1 min read

An Introduction to Synthetic Clinical Trial Data

2019-10-04-An-Introduction-to-Synthetic-Clinical-Trial-Data

Richard Hoptroff, Founder and CTO, Hoptroff; Lucy Mosquera, Director Data Science, Replica Analytics; Rebecca Li, Executive Director, Vivli; Ben Szekely, Director of Product, Cambridge Semantics

An overview of lessons learned and key observations from more than a decade of developing de-identification and other privacy enhancing technologies and applying them in practice globally.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.